Sofia Viegas
Biographic Data
| ID | 9065970 |
|---|---|
| NAME | Sofia Viegas |
| GIVEN NAMES | Sofia |
| FAMILY NAME | Viegas |
| SIGNATURE | VIEGAS S |
| AFFILIATIONS | Instituto Nacional de Saúde |
| ORCID | 0000-0002-8575-0657 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Genomic epidemiology of Sars-CoV-2 during the first four waves in Mozambique
Mozambique reported the first case of coronavirus disease 2019 (COVID-19) in March 2020 and it has since spread to all provinces in the country. To investigate the introductions and spread of SARS-CoV-2 in Mozambique, 1 142 whole genome sequences sampled within Mozambique were phylogenetically analyzed against a globally representative set, reflecting the first 25 months of the epidemic. The epidemic in the country was marked by four waves of inf…
Testing for Sars-CoV-2 in resource-limited settings
Early diagnosis of SARS-CoV-2 is fundamental to reduce the risk of community transmission and mortality, as well as public sector expenditures. Three years after the onset of the SARS-CoV-2 pandemic, there are still gaps on what is known regarding costs and cost drivers for the major diagnostic testing strategies in low- middle-income countries (LMICs). This study aimed to estimate the cost of SARS-CoV-2 diagnosis of symptomatic suspected patient…
No prominent works on this page.
Genomic epidemiology of Sars-CoV-2 during the first four waves in Mozambique
Mozambique reported the first case of coronavirus disease 2019 (COVID-19) in March 2020 and it has since spread to all provinces in the country. To investigate the introductions and spread of SARS-CoV-2 in Mozambique, 1 142 whole genome sequences sampled within Mozambique were phylogenetically analyzed against a globally representative set, reflecting the first 25 months of the epidemic. The epidemic in the country was marked by four waves of inf…
Testing for Sars-CoV-2 in resource-limited settings
Early diagnosis of SARS-CoV-2 is fundamental to reduce the risk of community transmission and mortality, as well as public sector expenditures. Three years after the onset of the SARS-CoV-2 pandemic, there are still gaps on what is known regarding costs and cost drivers for the major diagnostic testing strategies in low- middle-income countries (LMICs). This study aimed to estimate the cost of SARS-CoV-2 diagnosis of symptomatic suspected patient…
2019-20 coronavirus outbreak (2 works) · Biology (2 works) · Medicine (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · Virology (2 works) · Animal Virus Infections Studies (1 work) · Computational biology (1 work) · Computer Science (1 work) · COVID-19 diagnosis using AI (1 work) · Diagnostic test (1 work)